<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Physiochemical, Drug-likeness, pharmacokinetics and lipophilicity properties, Medicinal chemistry of choline.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="10">Properties of Choline (C
     <sub>5</sub>H
     <sub>14</sub>NO)
     <hr/>
    </th>
   </tr>
   <tr>
    <th>
     <italic>Physicochemical Properties</italic>
    </th>
    <th>choline</th>
    <th>
     <italic>Lipophilicity</italic>
    </th>
    <th>choline</th>
    <th>
     <italic>Druglikeness</italic>
    </th>
    <th>choline</th>
    <th>
     <italic>Pharmacokinetics</italic>
    </th>
    <th>choline</th>
    <th>Medicinal Chemistry</th>
    <th>choline</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>
     <italic>Molecular weight (gm/mol)</italic>
    </td>
    <td>104.1708</td>
    <td>
     <italic>Log P
      <sub>o/w</sub> (iLOGP)
     </italic>
    </td>
    <td>−2.41</td>
    <td>
     <italic>Lipinski</italic>
    </td>
    <td>yes</td>
    <td>
     <italic>GI absorption</italic>
    </td>
    <td>Yes</td>
    <td>PAINS</td>
    <td>0 alert</td>
   </tr>
   <tr>
    <td>
     <italic>Num.H-bond acceptors</italic>
    </td>
    <td>1</td>
    <td>
     <italic>Log P
      <sub>o/w</sub> (XLOGP3)
     </italic>
    </td>
    <td>−0.40</td>
    <td>
     <italic>Veber</italic>
    </td>
    <td>yes</td>
    <td>
     <italic>BBB permeant</italic>
    </td>
    <td>No</td>
    <td>Brenk</td>
    <td>1 alert</td>
   </tr>
   <tr>
    <td>
     <italic>Num. H-bond donors</italic>
    </td>
    <td>1</td>
    <td>
     <italic>Log P
      <sub>o/w</sub> (WLOGP)
     </italic>
    </td>
    <td>−0.32</td>
    <td>
     <italic>Ghose</italic>
    </td>
    <td>Partly yes (2 violation)</td>
    <td>
     <italic>P-gp substrate</italic>
    </td>
    <td>No</td>
    <td>Leadlikeness</td>
    <td>Partially yes (1 violation)</td>
   </tr>
   <tr>
    <td>
     <italic>No of rotatable bonds</italic>
    </td>
    <td>2</td>
    <td>
     <italic>Log P
      <sub>o/w</sub> (MLOGP)
     </italic>
    </td>
    <td>−3.46</td>
    <td>
     <italic>Egan</italic>
    </td>
    <td>yes</td>
    <td>
     <italic>Log K
      <sub>p</sub> (skin permeation)
     </italic>
    </td>
    <td>−7.22 cm/s</td>
    <td>Mutagenicity</td>
    <td>No</td>
   </tr>
   <tr>
    <td>
     <italic>Molar Refractivity</italic>
    </td>
    <td>29.69</td>
    <td>
     <italic>Log P
      <sub>o/w</sub> (SILICOS-IT)
     </italic>
    </td>
    <td>−0.57</td>
    <td>
     <italic>Bioavailability score</italic>
    </td>
    <td>137.87</td>
    <td>
     <italic>Water Solubility</italic>
    </td>
    <td>−1.26</td>
    <td>Liver and cardio cytotoxicity</td>
    <td>No</td>
   </tr>
   <tr>
    <td>
     <italic>Topological polar surface area TPSA (Å
      <sup>2</sup>)
     </italic>
    </td>
    <td>20.23 Å
     <sup>2</sup>
    </td>
    <td>
     <italic>Concensus Log Po/w</italic>
    </td>
    <td>−1.38</td>
    <td>
     <italic>Synthetic accessibility (SA)</italic>
    </td>
    <td>1.00</td>
    <td>
     <italic>Log S (SILICOS-IT)</italic>
    </td>
    <td>5.74e + 00</td>
    <td>The Maximum Recommended Therapeutic Dose (MRTD)</td>
    <td>5.2 mg/day</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
